Physician profile
Michael Daniel Gerstner
NPI 1215920350
$7,712.18
in general payments reported to CMS, 2019-2025
20 companies · $1,482 in 2025
The $1,482 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,546 · 2020: $50.38 · 2021: $1,903 · 2022: $919 · 2023: $1,013 · 2024: $799 · 2025: $1,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,095 · Consulting Fee: $800 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,094.54 |
| Consulting Fee | $800.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,656.83 | 2019-2025 | Air Optix, Total30, Precision7 |
| Heidelberg Engineering, INC. | $1,500.00 | 2021 | |
| Coopervision INC. | $1,116.64 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $823.55 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $594.95 | 2022-2025 | Infuse, Vyzulta, Miebo |
| Allergan, INC. | $415.01 | 2019-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $343.52 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $257.88 | 2025 | Acthar |
| Abbvie INC. | $164.24 | 2022-2025 | |
| Harrow Eye, LLC | $136.11 | 2025 | Vevye |
| Alcon Research LLC | $118.77 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $117.05 | 2024 | |
| Apellis Pharmaceuticals, INC. | $101.39 | 2023 | Syfovre |
| Biotissue Holdings INC. | $97.63 | 2021-2024 | |
| Maculogix, INC. | $94.00 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lombart Brothers, INC. | $64.32 | 2025 | Opd-III |
| Lkc Technologies, INC. | $55.54 | 2023 | |
| Thea Pharma INC. | $29.22 | 2025 | Iyuzeh |
| Novartis Pharmaceuticals Corporation | $13.03 | 2023 | |
| Oyster Point Pharma, INC. | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gerstner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.